| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 2.02 | 0.00 (0.00%) | 1.84 - 5.10 | 7.7 thousand (Below Avg) |
Market data as of 3:58PM 06/17/13. Quotes are delayed by at least 15 min.
| Open | 2.05 |
|---|---|
| Previous Close | 2.02 |
| Day's Range | 1.99 - 2.05 |
| Market Cap | 4.6M |
| Avg Volume (10 Day) | 340.1K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -4.48 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Pass |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Pass |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Fail |
NeuroMetrix to Exhibit at American Diabetes Association’s 73rd Scientific Sessions
Business Wire - Monday 06/10/2013 3:36 PM ET
NeuroMetrix Announces $5 Million Preferred Stock Placement
Business Wire - Tuesday 06/04/2013 6:06 PM ET
| NURO | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -27.98% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.00 | |
| LT Debt/Equity | 0.00 | |
| Earnings Yield | -- | |
| Price/Sales | 0.66 |
| Company | Last | Change |
|---|---|---|
| Pro-Dex Inc | 1.90 | 0.00% |
| Oculus Innovative Sciences Inc | 3.02 | -6.21% |
| IsoRay Inc | 0.58 | +4.14% |
| CAS Medical Systems Inc | 1.66 | -1.78% |
| Lakeland Industries Inc | 4.66 | -2.10% |
Data is delayed by at least 15 min.